List of participants — 2026

Nacimbio is a pharmaceutical holding company established by Rostec State Corporation in 2013 to advance the production of immunobiological medicinal products that are critical to Russia’s national security.

The company brings together two of Russia’s leading pharmaceutical manufacturers— NPO Microgen and FORT. Nacimbio’s activities include the research, development, full-cycle manufacturing, and commercialization of vaccines and toxoids, blood products, bacteriophages, allergens, allergoids, and other pharmaceutical products.

Contact information
Website: https://nacimbio.ru/en/

Arnest UniRus LLC is one of the largest manufacturers of fast moving consumer goods in Russia. Arnest UniRus produces cosmetics, home care products, ice cream, food products and biologically active additives. The company operates on 9 large manufacturing sites: ice cream and food products in Tula region, ice cream in Omsk, cosmetics and home care products in St. Petersburg, cosmetics and packaging in Ekaterinburg, cosmetics and perfume in Naro-Fominsk, biologically active additives in Biysk. In April 2026, the company also launched production in Navoiy, Uzbekistan. Our factories are equipped with innovative, high-tech machines that meet the most modern requirements for industrial safety and efficiency.

Contact information
Website: https://www.unirusgroup.ru/

The Moscow Center for Innovative Technologies in Healthcare, or Medtech. Moscow, was established at the initiative of the Mayor of Moscow in February 2022 to accelerate the development and integration of scientific innovations into clinical practice.

Here, Moscow physicians collaborate with scientists from leading Russian research institutions and startups to create new technologies and refine existing solutions for their rapid implementation in the city’s healthcare system. The Center supports scientific projects at every stage, including expert evaluation, patent protection, certification, regulatory approval, and the organization of serial production.

Key areas of focus include biotechnology, genetic and cellular technologies, the development of new materials and implants, 3D bioprinting, and artificial intelligence.

One of the central instruments for supporting innovative development is the Mayor of Moscow Grant Program, administered by Medtech since 2022.
Each year, more than 1 billion rubles are allocated for the development, testing, and implementation of advanced methods in diagnostics, treatment, and rehabilitation.

To date, 220 research projects have received support, some of which have been applied for the first time not only in Russia, but worldwide.

Medtech’s Technopark provides everything needed for the successful advancement of innovative medical technologies. Support programs available to residents and research teams help attract grants from federal and municipal development institutions, secure investment from Russian venture funds, and successfully navigate the medical technology registration process.

Contact information
Website: medtech.moscow
Email: mcitz@zdrav.mos.ru
Telegram: t.me/medtechmoscow
Vk: vk.com/medtechmoscow

BIOTECHNO LLC is a Russian leader in designing and manufacturing equipment for biotech, pharmaceutical, chemical, and food industries. For 25 years, the company has completed over 200 projects and supplied 1,000+ equipment units.

Production facilities in Moscow and Shchelkovo (3,000 m² total) cover the full cycle: engineering, machining, assembly, testing, and delivery.

Key products:
Laboratory, pilot, and industrial fermenters & bioreactors – a complete range from 3 to 2,000 liters for cell and microorganism cultivation. Features: unique lid with universal ports, precise control, and full aseptic operation.

Biotechno perfusion filtration system – for continuous cultivation, achieving cell densities tens of times higher than traditional methods. Shortlisted for the 2025 Industry Award (top 5).

Integrated lab-to-production lines – model upstream & downstream processes, enabling seamless scale‑up from R&D to industrial manufacturing.

All equipment is made of AISI 316L stainless steel, meets international standards, and supports Russia's technological sovereignty in biopharmaceuticals.

Contact information
Website: www.biotechno.ru
Email: moscow@biotechno.ru
Phone: 8 800 222-88-10

The Association of Pharmaceutical Companies "Innovative Pharma" (InPharma) brings together major pharmaceutical companies that actively invest in research and development and are counted among the top 20 global pharmaceutical producers.

Members of the Association have research facilities all over the world and also work with Russian R&D centers to conduct clinical trials, cooperating with more than 250 R&D facilities across Russia. Members of the Association carry out research and development in the key fields of medicine, such as cardiology, endocrinology, psychiatry, neurology, oncology, urology, gastroenterology and diabetology. With a view towards developing partnership for innovative pharmaceutical R&D, members of the Association enter into partnership agreements with the Russian development institutions — the Skolkovo Innovation Centre and the Russian Venture Capital Company, as well as develop projects to modernize the biomedicine and biopharmaceutical sectors in Russia, and invest in the construction of manufacturing facilities and research laboratories.

Contact information
Website: https://inpharma.info/en/